Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Cost of Revenue: 2018-2024

Historic Cost of Revenue for Burning Rock Biotech (BNR) over the last 7 years, with Dec 2024 value amounting to $26.2 million.

  • Burning Rock Biotech's Cost of Revenue rose 17.19% to -$62.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.9 million, marking a year-over-year increase of 140.62%. This contributed to the annual value of $26.2 million for FY2024, which is 25.04% down from last year.
  • Burning Rock Biotech's Cost of Revenue amounted to $26.2 million in FY2024, which was down 25.04% from $34.9 million recorded in FY2023.
  • Burning Rock Biotech's 5-year Cost of Revenue high stood at $53.7 million for FY2022, and its period low was $25.8 million during FY2020.
  • Its 3-year average for Cost of Revenue is $38.2 million, with a median of $34.9 million in 2023.
  • In the last 5 years, Burning Rock Biotech's Cost of Revenue soared by 84.08% in 2021 and then slumped by 35.02% in 2023.
  • Burning Rock Biotech's Cost of Revenue (Yearly) stood at $25.8 million in 2020, then spiked by 84.08% to $47.6 million in 2021, then increased by 12.88% to $53.7 million in 2022, then plummeted by 35.02% to $34.9 million in 2023, then declined by 25.04% to $26.2 million in 2024.